| RESULTS
By flow cytometry, HaCaT cells express low basal levels of PD-L1.
We were curious whether IL-17 or IL-22, cytokines essential in the immunopathogenesis of psoriasis, would alter PD-L1 expression in
HaCaT cells. As shown in Figure 1A , neither IL-17 nor IL-22 did so. Of note, the release of non-coding double-stranded RNA (dsRNA) from necrotic epithelial cells after cutaneous injury has been identified as an endogenous activator of TLR3. [6] Because the psoriatic microen- Expression of IL-36γ by HaCaT cells was then investigated in the presence of IL-17, IL-22, or poly (I:C). The proinflammatory effect of IL-36γ in skin is highly specific for the psoriatic state [7] attenuated by 
| CONCLUSIONS
In this study, TLR3 activation in poly (I:C)-treated keratinocytes was
shown to increase expression of PD-L1 and reduce IL-36γ expression in the presence of IL-17. Moreover, cutaneous injection of poly (I:C) relieved skin inflammation in a PD-L1-dependent manner, using our mouse model of psoriasis-like dermatitis. Chronic skin inflammation, such as psoriasis, is known to increase sensitivity to TLR3. In an inflammatory milieu, IFN-α (for example) enhances the expression of receptors that sense the TLR3 psoriatic agonist. [8] This implies that the AppendixS1 Materials and methods.
